Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDHelus Pharma Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 3 | -$0.83 | -$0.83 | -$0.83 |
| Q2 2026 | 3 | -$0.85 | -$0.85 | -$0.85 |
| Q3 2026 | 3 | -$0.72 | -$0.72 | -$0.72 |
| Q4 2026 | 1 | -$0.64 | -$0.64 | -$0.64 |
| Q1 2027 | 1 | -$0.57 | -$0.57 | -$0.57 |
| Q2 2027 | 1 | -$0.58 | -$0.58 | -$0.58 |
| Q3 2027 | 1 | -$0.49 | -$0.49 | -$0.49 |
| Q4 2027 | 1 | -$0.48 | -$0.48 | -$0.48 |
| Q1 2028 | 1 | -$0.36 | -$0.36 | -$0.36 |
Helus Pharma Inc. Earnings Date And Information
Helus Pharma Inc. last posted its earnings results on Tuesday, June 30th, 2026. The company reported $-0.95583 earnings per share for the quarter, topping analysts' consensus estimates of $-1.04 by $0.08417. The company had revenue of 0 for the quarter and had revenue of -44,684,342 for the year. Helus Pharma Inc. has generated $-4 earnings per share over the last year ($-4.23 diluted earnings per share) and currently has a price-to-earnings ratio of -2.82. Helus Pharma Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Helus Pharma Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/30/2026 | Q4 2026 | N/A | -$0.92 | N/A | $0 | $0 |
| 12/31/2025 | Q3 2026 | N/A | -$1.76 | N/A | N/A | $0 |
| 10/29/2025 | Q2 2026 | N/A | -$1.94 | N/A | N/A | $0 |
| 08/13/2025 | Q1 2026 | N/A | -$1.10 | N/A | N/A | $0 |
| 06/30/2025 | Q4 2025 | N/A | -$1.46 | N/A | N/A | $0 |
| 02/10/2025 | Q3 2025 | N/A | -$0.54 | N/A | N/A | $0 |
| 11/13/2024 | Q2 2025 | -$0.98 | -$2.84 | -1.86 | N/A | $0 |
| 08/08/2024 | Q1 2025 | -$0.97 | -$0.55 | 0.42 | N/A | $0 |
| 03/31/2024 | Q4 2024 | N/A | -$1.07 | N/A | N/A | $0 |
| 02/14/2024 | Q3 2024 | -$1.22 | -$3.45 | -2.23 | N/A | $0 |
| 11/14/2023 | Q2 2024 | N/A | -$1.93 | N/A | N/A | $0 |
| 08/14/2023 | Q1 2024 | N/A | -$2.68 | N/A | N/A | $0 |
| 03/31/2023 | Q4 2023 | N/A | -$2.66 | N/A | N/A | $0 |
| 02/14/2023 | Q3 2023 | N/A | -$2.16 | N/A | N/A | $0 |
| 11/14/2022 | Q2 2023 | N/A | -$2.10 | N/A | N/A | $0 |
| 08/08/2022 | Q1 2023 | N/A | -$2.82 | N/A | N/A | $0 |
| 03/31/2022 | Q4 2022 | N/A | -$3.96 | N/A | N/A | $0 |
| 02/10/2022 | Q3 2022 | N/A | -$3.81 | N/A | N/A | $0 |
| 11/15/2021 | Q2 2022 | N/A | -$4.04 | N/A | N/A | $0 |
| 08/16/2021 | Q1 2022 | N/A | -$3.55 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Helus Pharma Inc. Earnings: FAQ's
In the previous quarter, Helus Pharma Inc. (:HELP) reported $-0.95583 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.04 by $0.08417.
The conference call for Helus Pharma Inc.'s latest earnings report can be listened to online.
The conference call transcript for Helus Pharma Inc.'s latest earnings report can be read online.
Helus Pharma Inc. (:HELP) has a recorded annual revenue of $-44,684,342.
Helus Pharma Inc. (:HELP) has a recorded net income of $-147,053,896.Helus Pharma Inc. has generated $-4.23 earnings per share over the last four quarters.
Helus Pharma Inc. (:HELP) has a price-to-earnings ratio of -2.82 and price/earnings-to-growth ratio is -0.12.